Mirtazapine-Induced Hyponatremia in a Patient with Systemic Mastocytosis and Generalized Anxiety Disorder

Psychiatr Danub. 2023 Spring;35(1):126-127. doi: 10.24869/psyd.2023.126.
No abstract available

MeSH terms

  • Antidepressive Agents, Tricyclic / adverse effects
  • Anxiety Disorders / drug therapy
  • Humans
  • Hyponatremia* / chemically induced
  • Mastocytosis, Systemic* / complications
  • Mastocytosis, Systemic* / drug therapy
  • Mianserin / adverse effects
  • Mirtazapine / therapeutic use

Substances

  • Mirtazapine
  • Antidepressive Agents, Tricyclic
  • Mianserin